Page last updated: 2024-09-02

fingolimod hydrochloride and minocycline

fingolimod hydrochloride has been researched along with minocycline in 2 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(minocycline)
Trials
(minocycline)
Recent Studies (post-2010) (minocycline)
2,7711572,0626,5795022,921

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)minocycline (IC50)
Multidrug transporter MdfAEscherichia coli K-122.6

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burton, JM; O'Connor, P1
Hahn, JN; Kaushik, DK; Mishra, MK; Silva, C; Wang, J; Yong, VW1

Reviews

1 review(s) available for fingolimod hydrochloride and minocycline

ArticleYear
Novel oral agents for multiple sclerosis.
    Current neurology and neuroscience reports, 2007, Volume: 7, Issue:3

    Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cladribine; Clinical Trials as Topic; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Isoxazoles; Leflunomide; Minocycline; Multiple Sclerosis; Mycophenolic Acid; Propylene Glycols; Pyridones; Quinolones; Sphingosine

2007

Other Studies

1 other study(ies) available for fingolimod hydrochloride and minocycline

ArticleYear
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
    Journal of immunology (Baltimore, Md. : 1950), 2016, 11-15, Volume: 197, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Basigin; Central Nervous System; Clinical Trials, Phase III as Topic; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Fumarates; Humans; Interferon-beta; Lymphocyte Activation; Maleates; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Minocycline; Monocytes; Multiple Sclerosis; T-Lymphocytes; Tissue Inhibitor of Metalloproteinase-1

2016